marketinsider

Attention Shareholders: Don’t Miss Out on Your Rights! Pomerantz Law Firm Reminds Investors of Class Action Lawsuit Against Elanco Animal Health Incorporated and Upcoming Deadlines for Losses

The Impact of the Class Action Lawsuit Against Elanco Animal Health Incorporated Introduction Recently, Pomerantz LLP announced that a class action lawsuit has been filed against Elanco Animal Health Incorporated (“Elanco” or the “Company”) and certain officers. The lawsuit, filed in the United States District Court for the District Of Maryland, alleges that the Company…

Read More

Get the Scoop: Banco Santander’s Q3 2024 Earnings Call Transcript is Here and It’s a Must-Read!

It’s Earnings Season: Banco Santander, S.A. Q3 2024 Conference Call Recap The Players As the sun rose on October 29, 2024, the financial world tuned into Banco Santander, S.A.’s Q3 earnings conference call. Leading the charge were Begona Morenes, Global Head of Investor Relations; Jose Garcia Cantera, the Senior Executive Vice-President and Chief Financial Officer;…

Read More

Unveiling the Numbers: A Recap of Shutterstock Inc.’s Q3 2024 Earnings Call

Shutterstock Q3 2024 Earnings Conference Call Highlights Key Speakers: Rik Powell – Senior Vice President, Finance and IR Paul Hennessy – Chief Executive Officer Jarrod Yahes – Chief Financial Officer Conference Call Participants: Curt Nagle – Bank of America Youssef Squali – Truist Securities Bernie McTernan – Needham & Company Matthew Cost – MS Andrew…

Read More

Innovative and Articulate: Protagenic Therapeutics Announces Pricing of Private Placement for $12.75 Million

Protagenic Therapeutics Announces Purchase Agreement for 1,948,295 Shares of Common Stock New York, NY / ACCESSWIRE / October 29, 2024 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) Biopharmaceutical Innovation Protagenic Therapeutics, a leader in biopharmaceutical innovation, has recently made a significant announcement regarding a purchase agreement for the sale of an aggregate of 1,948,295 shares of common…

Read More

Mark your calendars! Electromed Inc. to Unveil First Quarter Fiscal 2025 Financial Results on November 12, 2024 at 5:00 PM ET

Exciting News from Electromed, Inc. Get Ready for the Big Announcement! Hey there, readers! Do we have some exciting news for you today! Electromed, Inc., a leading provider of innovative airway clearance technologies, has just announced that they will be releasing their financial results for the fiscal 2025 first quarter on November 12, 2024. If…

Read More

Mark your calendars! BrainsWay’s Third Quarter 2024 Financial Results are coming on November 12, 2024 – get ready to geek out with us!

Welcome to the latest news in mental health technology! Exciting Updates from BrainsWay Ltd. BURLINGTON, Mass. and JERUSALEM, Oct. 29, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its third quarter…

Read More